BFK — Pharmesis International Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Pharmesis International, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	14	19.7	9.48	4.6	4.31
Net Total Accounts Receivable
Net Total Receivables	14.2	12.9	8.31	37.7	17.6
Total Inventory
Prepaid Expenses
Total Current Assets	37.1	44.2	33.3	56.5	38.3
Net Property, Plant And Equipment	53.1	51.3	50.2	56.6	16.2
Net Goodwill
Long Term Investments
Other Long Term Assets
Total Assets	92.7	97.9	85.9	116	95.7
Accounts Payable
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	30.8	39.6	30.6	53.6	39.9
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	35.2	44	34.8	54.3	40.2
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	57.5	53.9	51.1	61.6	55.5
Total Liabilities & Shareholders' Equity	92.7	97.9	85.9	116	95.7
Total Common Shares Outstanding